.png)
About Artroa
Eva Skiöldebrand-
Founder of biomarkers and pharmaceutical
Eva Skiöldebrand is a veterinarian
and professor at the Swedish
University of Agricultural Sciences in
Uppsala. Her research area primarily
focuses on osteoarthritis, with a
particular emphasis on biomarkers
for diagnosis and drug development
in horses. Her work also adopts a
translational perspective, aiming to
apply the findings to human
medicine.With a substantial
background in the pharmaceutical
industry her expertise spans both
veterinary and human medicine,
making her research impactful and
relevant to both fields.
​
Foto: Addlight/Göran Ekeberg
Anders Lindahl -
Founder of biomarkers and pharmaceutical
Professor in clinical chemistry and transfusion-medicine at Gothenburg University. He is chief doctor specialized in clinical chemistry and cell-therapy, and has been COO at Sahlgrenska University Hospital for over 10 years. He is the founder of Cell Matrix AB and co-founder of Cellartis AB.
Stina Ekman -
Founder of biomarkers
Professor in special pathology at the Swedish University of Agricultural Sciences. She is a Diplomate of ECVP and her expertise is in pathology of the locomotor system, with focus on osteoarthritis and osteochondrosis in domestic animals. She has a vast experience in different morphologic techniques.
​
Foto: Addlight/Göran Ekeberg
Elisabeth Hansson -
Founder of pharmaceutical
Professor in neurobiology at the Sahlgrenska Academy, University of Gothenburg. She is doing research on pharmacological substances in network coupled cells, the supporting cells in different organs in the body. These networks can be affected by inflammatory stimuli and become dysregulated. It can give rise to systemic inflammation, which in turn can lead to pain that can turn into chronic.
Founder and owner of the treatment drug.
Kristin Abrahamsson Aurell-Founder of pharmaceutical
Sporthorse veterinarian since 1996, specializing in orthopedics and surgery. Head of a equine clinic at Kungsbacka, Sweden
Founder and owner of the treatment drug